Cardiotoxicity after cancer treatment: a process map of the patient treatment journey

Cardio-Oncology
Robyn A ClarkBogda Koczwara

Abstract

Cardiotoxicity is a potential complication of anticancer therapy. While guidelines have been developed to assist practitioners, an effective, evidence based clinical pathway for the treatment of cardiotoxicity has not yet been developed. The aim of this study was to describe the journey of patients who developed cardiotoxicity through the healthcare system in order to establish baseline data to inform the development and implementation of a patient-centred, evidence-based clinical pathway. Mixed-methods design with quantitative and qualitative components using process mapping at 3 large medical centres in 2 states between 2010 and 2015. Fifty (50) confirmed cases of cardiotoxicity were reviewed (39 medical record reviews, 7 medical record review and interviews and 4 internview only). The mean age at cancer diagnosis of this group was 53.3 years (range 6-89 years); 50% female; 30% breast cancer, 23% non-Hodgkin's lymphoma; mean chemotherapy cycles 5.2 (median 6; range 1-18); 49 (89%) presented to chemotherapy with pre-existing cardiovascular risk factors; 39 (85%) had at least one modifiable risk factor and 11 (24%) had more than 4; 44 (96%) were diagnosed by echocardiogram and 27 (57%) were referred to a cardiologist (only 7 (1...Continue Reading

References

Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezAllan S Jaffe
Nov 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John J DoyleDawn L Hershman
Jun 13, 2009·Journal of the American College of Cardiology·Edward T H Yeh, Courtney L Bickford
Feb 2, 2010·Journal of the American College of Cardiology·Daniela CardinaleCarlo M Cipolla
Aug 17, 2010·BMJ : British Medical Journal·Timothy M TrebbleMarc Baker
Aug 24, 2010·Progress in Cardiovascular Diseases·Douglas L Mann, Ronald J Krone
Aug 24, 2010·Progress in Cardiovascular Diseases·Douglas B SawyerChee Chew Lim
Aug 24, 2010·Progress in Cardiovascular Diseases·Joseph R Carver
Aug 24, 2010·Progress in Cardiovascular Diseases·Quinn S Wells, Daniel J Lenihan
Sep 16, 2010·Current Hypertension Reports·Carrie Anna Geisberg, Douglas B Sawyer
Sep 25, 2010·Cancer Treatment Reviews·Cyrus ChargariYoulia M Kirova
Oct 20, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AaproU Wedding
Nov 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Søren Astrup JensenJens Benn Sørensen
Dec 4, 2010·Cancer Treatment Reviews·Elżbieta Senkus, Jacek Jassem
Jun 29, 2011·Journal of Exercise Science and Fitness·Daniel C HughesKaren M Basen-Engquist
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CuriglianoUNKNOWN ESMO Guidelines Working Group
Apr 2, 2013·Seminars in Oncology·Daniela CardinaleCarlo M Cipolla
Apr 2, 2014·The American Journal of Cardiology·Cyrus ChargariNicolas Magné
May 6, 2014·The Breast : Official Journal of the European Society of Mastology·Felipe AdesEvandro de Azambuja
Aug 21, 2015·Nature Reviews. Cardiology·Michael S Ewer, Steven M Ewer
Mar 19, 2016·Circulation Research·Carrie G Lenneman, Douglas B Sawyer
Sep 25, 2016·Heart, Lung & Circulation·Laura AlstonMelanie Nichols
Aug 22, 2017·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Cinzia LorenziniCristiana Corsi
Sep 10, 2017·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Citations

Jan 17, 2020·European Journal of Heart Failure·Valentina Bracun, Rudolf A de Boer
Feb 20, 2021·Current Opinion in Supportive and Palliative Care·Jiliu PanAlexander R Lyon

❮ Previous
Next ❯

Software Mentioned

Excel
SPSS®

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Related Papers

Cancer Investigation
K A Tolba, E N Deliargyris
Angiology
I VasiliadisD P Mikhailidis
Current Cardiology Reviews
Maysa M Abu-Khalaf, Feras Bader
Cancer Control : Journal of the Moffitt Cancer Center
K J ViesonR Bradbury
Texas Heart Institute Journal
Jose BanchsW Gregory Hundley
© 2021 Meta ULC. All rights reserved